Delivery Order SPE2DB25D3109-SPE2DB25FPKVP
Award Date 7/24/25
Potential Completion Date 7/25/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Xcopri 100 mg tablets (30-count units) with a ceiling value of $2,947.40. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The contract has an ultimate completion date of July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,601.47 on December 2, 2025, for the supply of Xcopri 200 mg tablets (30-count packages). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 3, 2025, with performance to be executed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Xcopri 100 mg tablets (30-count) valued at $2,733.37 under a firm fixed-price contract. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award carries no set-aside designation and was competitively...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Xcopri 100 mg tablets (30-count units) with a contract ceiling value of $13,696.56. This firm fixed-price delivery order, valued at approximately $13.7K, represents a competitive award with no set-aside designation and is scheduled for completion by November 17, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Xcopri 100 mg tablets (30-count packaging) valued at $1,037.97. This firm fixed-price delivery order, with an ultimate completion date of August 18, 2025, represents a competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Xcopri 50 mg tablets (30-count units) with a contract ceiling value of $3,145.57 and an ultimate completion date of January 6, 2026. This non-set-aside, competitively awarded delivery order employs firm fixed pricing and is being performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,373.18 on December 9, 2025, for the supply of Xcopri 100 mg tablets (30-count units). This firm fixed-price delivery order, with an ultimate completion date of December 10, 2025, represents a non-competitive set-aside contract fulfilling pharmaceutical supply needs for the federal government. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $4,857.44 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Xcopri 50 mg tablets (30-count units). This firm fixed-price contract, with an ultimate completion date of June 2, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,916.59 to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Xcopri 50 mg tablets (30-count packaging). This firm fixed-price delivery order, which is not a set-aside contract, represents a competitive award under DLA's broader pharmaceutical procurement framework. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 9,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,948.56 by the Defense Logistics Agency on December 9, 2025, for the supply of Xcopri 50 mg tablets (30-count units). This firm fixed-price, competitively awarded contract carries an ultimate completion date of December 10, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...